Immunological insights into the pathogenesis of active CMV infection in non-immunosuppressed critically ill patients

Journal of Medical Virology

Volumn 83, Issue 11, 2011, Pages 1966-1971

  Blanquer, José ^a   Chilet, Marifina ^a   Benet, Isabel ^a   Aguilar, Gerardo ^a   Muñoz Cobo, Beatriz ^a   Tellez, Alexander ^a   Costa, Elisa ^a   Bravo, Dayana ^a   Navarro, David ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

CMV DNA load; Cytomegalovirus; IL 10; IL 6; Intensive care unit patients; T cell immunity

Indexed keywords

GAMMA INTERFERON; GANCICLOVIR; INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PATHOGENESIS; VIRUS LOAD;

AGED; AGED, 80 AND OVER; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CRITICAL ILLNESS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; RESPIRATORY SYSTEM; VIRAL LOAD;

CYTOMEGALOVIRUS;

EID: 80052716184     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22202     Document Type: Article

References (30)

1. Brodeur ND, Spencer JV. 2010. Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity. Virus Res 153: 265-268.
2. Brockman MA, Kwon DS, Tighe DP, Pavlik DF, Rosato PC, Sela J, Porichis F, Le Gall S, Waring MT, Moss K, Jessen H, Pereyra F, Kavanagh DG, Walker BD, Kaufmann DE. 2009. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Bood 114: 346-356.
3. Cervera C, Filella X, Linares L, Pineda M, Esteva C, Antón A, Marcos MA, Cofán F, Navasa M, Pérez-Villa F, Pumarola T, Moreno A. 2007. TH1/TH2 cytokine release pattern during in vivo cytomegalovirus disease in solid organ transplantation. Transplant Proc 39: 2233-2235.
4. Chilet M, Aguilar G, Benet I, Belda J, Tormo N, Carbonell JA, Clari MA, Costa E, Navarro D. 2010. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol 82: 1384-1391.
5. Collard HR, Schwarz MI. 2004. Diffuse alveolar hemorrhage. Clin Chest Med 25: 583-592.
6. Cook CH, Zhang Y, McGuiness BJ, Lahm MC, Sedmak DD, Ferguson RM. 2002. Intra-abdominal infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J Infect Dis 185: 1395-1400.
7. Cook CH, Martin LC, Yenchar JK, Lahm MC, McGuinness B, Davies EA, Ferguson RM. 2003. Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med 31: 1923-1929.
8. Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD. 2006. Lypopolysaccharide, tumor necrosis factor alpha, or interleukin-1β triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol 80: 9151-9158.
9. Gimeno C, Solano C, Latorre JC, Hernández-Boluda JC, Clari MA, Remigia MJ, Furió S, Calabuig M, Tormo N, Navarro D. 2008. Quantification of DNA in plasma by an automated real-time PCR assay (CMV PCR Kit, Abbott) for surveillance of active cytomegalovirus infection and guidance of pre-emptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 46: 3311-3318.
10. Griffiths PD. 2010. Cytomegalovirus in intensive care. Rev Med Virol 20: 1-3.
11. Humphreys IR, de Trez C, Kinkade A, Benedict CA, Croft M, Ware CF. 2007. Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J Exp Med 204: 1217-1225.
12. Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P, White K, Corey L, Boeckh M. 2003. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: Impact of host factors, drug therapy, and subclinical reactivation. Blood 102: 3060-3067.
13. Kalil AC, Florescu DF. 2009. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 37: 2350-2358.
14. Krishnan A, Zhou W, Lacey SF, Limaye AP, Diamond DJ, La Rosa C. 2010. Programmed death-1 receptor and interleukin-10 in liver transplant recipients at high risk for late cytomegalovirus disease. Transpl Infect Dis 12: 363-370.
15. Jinquan T, Larsen CG, Gesser B, Matsushima K, Thestrup-Pedersen K. 1993. Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration. J Immunol 151: 4545-4551.
16. Jones M, Ladell K, Wynn KK, Stacey MA, Quigley MF, Gostick E, Price DA, Humphreys IR. 2010. IL-10 restricts memory T cell inflation during cytomegalovirus infection. J Immunol 185: 3583-3592.
17. Limaye AP, Boeckh M. 2010. CMV in critically ill patients: Pathogen or bystander? Rev Med Virol 20: 372-379.
18. Mosmann TR. 1994. Properties and functions of interleukin-10. Adv Immunol 56: 1-26.
19. Nordøy I, Müller F, Nordal KP, Rollag H, Lien E, Aukrust P, Froland SS. 2000. The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. J Infect Dis 181: 51-57.
20. Oberg HH, Juricke M, Kabelitz D, Wesch D. 2011. Regulation of T cell activation by TLR ligands. Eur J Cell Biol 90: 582-592.
21. Osawa R, Singh N. 2009. Cytomegalovirus infection in critically ill patients: A systematic review. Crit Care 13: 1-10.
22. Prosch S, Wendt CE, Reinke P, Liebenthal C, Stamminger T, Volk HD, Krüger DH. 1995. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60cells by TNFalpha is mediated via induction of NF-KappaB. Virology 208: 197-206.
23. + T cells early after allogeneic stem cell transplantation may identify patients at risk of active CMV infection. Haematologica 93: 1434-1436.
24. Solano C, Navarro D. 2010. Clinical virology of cytomegalovirus infection following hematopoietic transplantation. Future Virol 5: 111-124.
25. Tormo N, Solano C, Benet I, Clari MA, Nieto J, de la Cámara R, López J, López-Aldeguer N, Hernández-Boluda JC, Remigia MJ, Garcia-Noblejas A, Gimeno C, Navarro D. 2010. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8(+) and CD4(+) T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 45: 543-549.
26. Von Muller L, Klemm A, Durmus N, Weiss M, Suger-Wiedeck H, Schneider M, Hampl W, Mertens T. 2007. Cellular immunity and active cytomegalovirus infection in patients with septic shock. J Infect Dis 196: 1288-1295.
27. Ward NS, Casserly B, Ayala A. 2008. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 29: 617-625.
28. Widmann T, Sester U, Gärtner BC, Schubert J, Pfreundschuh M, Köhler H, Sester M. 2008. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. PLoS One 3: e3634.
29. Zedtwitz-Liebenstein K, Schenk P, Apfalter P, Fuhrmann V, Stoiser B, Graninger W, Schuster E, Frass M, Burgmann H. 2005. Ventilator-associated pneumonia: Increased bacterial counts in bronchoalveolar lavage by using urea as an endogenous marker of dilution. Crit Care Med 33: 756-759.
30. Zedtwitz-Liebenstein K, Jaksch P, Wulkersdorfer B, Friehs H, Pempelfort SD, Burgmann H, Frass M. 2007. Usefulness of interleukin-10 detection in lung transplant patients with human cytomegalovirus infection with respect to virus persistence. Transplantation 84: 268-271.